| Name |
Recombinant Human C1qL3 Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9115-TN
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
E. coli -derived Ser122 - Asp255, with an N-terminal Met and 6-His tag
|
| Purity |
>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human C1qL3 is immobilized at 2 μg/mL, 100 μL/well, the concentration of Recombinant Human BAI2 Fc Chimera that produces 50% of the optimal binding response is approximately 25-150 ng/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
Q5VWW1
|
| Gene |
C1QL3
|
| Sequence |
Met
|
| Supplier Page |
Shop
|
When Recombinant Human C1qL3 (Catalog # 9115-TN) is coated at 1 µg/mL, Recombinant Human BAI2 Fc Chimera binds with a typical ED 50 of 10-60 ng/mL.